Chia-Chi Wang

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 12

Top Topics

Body Composition

Hepatitis C Virus

Helicobacter Pylori Infection

Prognostic Factors

Top Venues

Hepatology international

Alimentary pharmacology & therapeutics

Journal of gastroenterology and hepatology

Digestive diseases and sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Shao-Wen Wang, Tsung-Han Hsieh, Yu-Ming Cheng, Chia-Chi Wang, Jia-Horng Kao
Liver and atherosclerotic risks of patients with cryptogenic steatotic liver disease. Hepatology international 18 (3) (2024)
Shao-Wen Wang, Tsung-Han Hsieh, Yu-Ming Cheng, Chia-Chi Wang, Jia-Horng Kao
Liver and atherosclerotic risks of patients with cryptogenic steatotic liver disease. Hepatology international (2024)
Shao-Wen Wang, Tsung-Han Hsieh, Yu-Ming Cheng, Chia-Chi Wang, Jia-Horng Kao
Liver and atherosclerotic risks of patients with cryptogenic steatotic liver disease. Hepatology international 18 (3) (2024)
Kun-Lin Cheng, Yu-Ming Cheng, Cheng-Yi Chan, Chia-Chi Wang
Predictors of Liver Dysfunction After Transhepatic Arterial Chemo-embolization in Hepatocellular Carcinoma Patients. Digestive diseases and sciences (2023)
Yu-Ming Cheng, Chia-Chi Wang, Jia-Horng Kao
Metabolic associated fatty liver disease better identifying patients at risk of liver and cardiovascular complications. Hepatology international (2022)
Meng-Hsuan Hsieh, Ming-Jong Bair, Pei-Chien Tsai, Kuo-Chih Tseng, Ching-Chu Lo, Chi-Yi Chen, Hsing-Tao Kuo, Chao-Hung Hung, Hsueh-Chou Lai, Cheng-Yuan Peng, Jing-Houng Wang, Jyh-Jou Chen, Pei-Lun Lee, Rong-Nan Chien, Chi-Chieh Yang, Gin-Ho Lo, Jia-Horng Kao, Chun-Jen Liu, Chen-Hua Liu, Sheng-Lei Yan, Chun-Yen Lin, Wei-Wen Su, Cheng-Hsin Chu, Chih-Jen Chen, Shui-Yi Tung, Chi-Ming Tai, Chih-Wen Lin, Pin-Nan Cheng, Yen-Cheng Chiu, Chia-Chi Wang, Jin-Shiung Cheng, Wei-Lun Tsai, Han-Chieh Lin, Yi-Hsiang Huang, Ming-Lun Yeh, Chung-Feng Huang, Jee-Fu Huang, Chia-Yen Dai, Ming-Lung Yu, Wan-Long Chuang, null null
Long-term risk of end-stage renal diseases with maintenance dialysis among chronic hepatitis C patients after antiviral therapy in Taiwan. Journal of gastroenterology and hepatology 36 (8) (2021)
Wei-Fan Hsu, Pei-Chein Tsai, Chi-Yi Chen, Kuo-Chih Tseng, Hsueh-Chou Lai, Hsing-Tao Kuo, Chao-Hung Hung, Shui-Yi Tung, Jing-Houng Wang, Jyh-Jou Chen, Pei-Lun Lee, Ron-Nan Chien, Chun-Yen Lin, Chi-Chieh Yang, Gin-Ho Lo, Chi-Ming Tai, Chih-Wen Lin, Jia-Horng Kao, Chun-Jen Liu, Chen-Hua Liu, Sheng-Lei Yan, Ming-Jong Bair, Wei-Wen Su, Cheng-Hsin Chu, Chih-Jen Chen, Ching-Chu Lo, Pin-Nan Cheng, Yen-Cheng Chiu, Chia-Chi Wang, Jin-Shiung Cheng, Wei-Lun Tsai, Han-Chieh Lin, Yi-Hsiang Huang, Jee-Fu Huang, Chia-Yen Dai, Wan-Long Chuang, Ming-Lung Yu, Cheng-Yuan Peng
Hepatitis C virus eradication decreases the risks of liver cirrhosis and cirrhosis-related complications (Taiwanese chronic hepatitis C cohort). Journal of gastroenterology and hepatology 36 (10) (2021)
Yu-Ming Cheng, Jia-Horng Kao, Chia-Chi Wang
The metabolic profiles and body composition of lean metabolic associated fatty liver disease. Hepatology international 15 (2) (2021)
Tzu-Hsiang Kung, Chia-Chi Wang
Letter: programmed cell death protein-1 (PD-1)-targeted immunotherapy in advanced hepatocellular carcinoma: efficacy and safety data from an international multicentre real-world cohort-more questions than answers. Alimentary pharmacology & therapeutics 50 (2) (2020)
Hung-Da Chen, Chia-Chi Wang
Letter: severe vitamin D deficiency is a prognostic biomarker in autoimmune hepatitis-offender or bystander? Alimentary pharmacology & therapeutics 49 (7) (2020)
Kai-Hsiang Liang, Chia-Chi Wang
Letter: outcomes after hepatic encephalopathy in population-based cohorts of patients with cirrhosis-more questions than answers? Alimentary pharmacology & therapeutics 52 (4) (2020)
Chia-Chi Wang, Pin-Nan Cheng, Jia-Horng Kao
Systematic review: chronic viral hepatitis and metabolic derangement. Alimentary pharmacology & therapeutics 51 (2) (2019)